Zimmer Biomet

Yahoo Finance • 4 hours ago

Zimmer Biomet (ZBH) Q4 2025 Earnings Transcript

Image source: The Motley Fool. Date Tuesday, Feb. 10, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer — Ivan Tornos Executive Vice President & Chief Financial Officer — Suketu Upadhyay Vice President, Investor Relations... Full story

Yahoo Finance • 6 hours ago

Zimmer Biomet beats quarterly estimates on strong hips, knees device demand

Feb 10 (Reuters) - Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company capitalized ​on steady demand for its devices used in orthopedic procedures. Shares ‌of the Warsaw, Indiana based... Full story

Yahoo Finance • 9 hours ago

Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data

Precedence Research Precedence Research, a leading strategic research firm, presents an in-depth analysis of the Tissue and Regenerative Engineering market, highlighting key company performance, product focus, and government funding initi... Full story

Yahoo Finance • 20 hours ago

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * The Coca-Cola Company (KO [https://seekingalpha.com/symbol/KO]) * CVS Health Corporation (CVS [https://seekingalpha.com/symbol/CVS]) * BP p.l.c. (BP [https://seekingalpha... Full story

Yahoo Finance • 8 days ago

Hip Replacement Market to Reach US$ 11.4 Billion by 2033 Driven by Aging Population, Rising Osteoarthritis, and Robotic-Assisted Surgery Says Astute Analytica

AstuteAnalytica India Pvt. Ltd. The global hip replacement market is experiencing significant growth, driven by an aging population, rising obesity, and advancements in robotic-assisted surgery. Key trends include increasing demand for mi... Full story

Yahoo Finance • 2 months ago

Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference

WARSAW, Ind., Dec. 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the 44th Annual J.P.... Full story

Yahoo Finance • 2 months ago

NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ...

This article first appeared on GuruFocus. Product Revenue: Increased 907% to $2.7 million in Q4 FY2025; 163% to $9.1 million for the full fiscal year 2025. License Revenue: $3 million in fiscal 2025 from the expanded exclusive distributio... Full story

Yahoo Finance • 2 months ago

Roku upgraded, Lockheed downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded Roku (ROKU) to... Full story

Yahoo Finance • 2 months ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Thinkstock Quick Read The rotation trade had another run on Wall Street Monday, as tech stocks led the selling once again. While the move away from the AI/Data center trade has gained some strength, the reality is that with a likely thir... Full story

Yahoo Finance • 2 months ago

Assessing Zimmer Biomet After Share Price Weakness and Discounted Cash Flow Outlook

Wondering if Zimmer Biomet Holdings is quietly becoming a value opportunity, or if the recent weakness is a warning sign? Let us walk through what the numbers are really saying about the stock. The share price is down about 2.9% over the l... Full story

Yahoo Finance • 3 months ago

Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman

SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and... Full story

Yahoo Finance • 3 months ago

Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The Hip Replacement industry is poised for substantial growth, projected to reach US$ 10.24 billion by 2033, up from US$ 6.92 billion in 2024, at a CAGR of 4.45% between 2025 and 2033. This expansion is driven by increased aw... Full story

Yahoo Finance • 3 months ago

Viscosupplementation Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The viscosupplementation market is projected to grow robustly, reaching US$ 10.16 billion by 2033 from US$ 4.66 billion in 2024, with a CAGR of 9.02% from 2025 to 2033. This minimally invasive treatment involves injecting hya... Full story

Yahoo Finance • 3 months ago

How Analyst Revisions Are Shaping the Evolving Story for Zimmer Biomet

Zimmer Biomet Holdings has seen its consensus analyst price target decrease slightly from $104.84 to $102.92, reflecting a cautious reassessment among market watchers. While updated product launches and strategic moves such as the FNA acqu... Full story

Yahoo Finance • 3 months ago

Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Gauzy Ltd. (NASDAQ:GAUZ) and Zimmer Biomet Holdings, Inc. (NYSE:ZBH).... Full story

Yahoo Finance • 3 months ago

Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company’s possible... Full story

Yahoo Finance • 3 months ago

Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible vio... Full story

Yahoo Finance • 3 months ago

Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) inv... Full story

Yahoo Finance • 3 months ago

The SPAIN-US CHAMBER of COMMERCE in Florida Celebrates Its 45th Anniversary Gala With Over 420 Business Leaders and Renowned Figures in Miami

Henkell Freixenet was honored with the Ponce de León Company of the Year Award, while Iván Tornos, Chairman, President & CEO of Zimmer Biomet Holdings, Inc. (S&P 500), received the Ponce de León Corporate Leader of the... Full story

Yahoo Finance • 3 months ago

Zimmer Biomet (ZBH) Gives Up 15% on Weak Q3

We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the worst-performing stocks on Wednesday. Zimmer dropped its share prices by 15.15 percent on Wednesday to end at $87.55... Full story